https://www.takarabio.com/applications/mrna-and-protein-therapeutics
mRNA and protein therapeutics
Discover how our products are helping researchers overcome challenges in their vaccine development workflows.
mrna and protein therapeutics
https://www.pptaglobal.org/
Home - Plasma Protein Therapeutics Association
The Plasma Protein Therapeutics Association (PPTA) represents the manufacturers of plasma-derived and recombinant analog therapies.
protein therapeuticsplasmaassociation
https://www.culturebiosciences.com/applications/protein-therapeutics
Protein Therapeutics Development & Upstream Bioprocessing
protein therapeuticsupstream bioprocessingdevelopment
https://www.kymeratx.com/
Revolutionary Medicines Catalyzed by Protein Degradation | Kymera Therapeutics
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
by proteinrevolutionarymedicinescatalyzeddegradation
https://www.stablix.com/
Stablix | Protein Stabilization Therapeutics
Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.
protein stabilizationtherapeutics
https://c4therapeutics.com/our-science/learn-about-targeted-protein-degradation/
Learn About Targeted Protein Degradation - C4 Therapeutics
targeted protein degradationlearn aboutc4 therapeutics
https://www.bioaegistherapeutics.com/
Plasma Gelsolin Immune Protein | BioAegis Therapeutics
Dec 12, 2025 - BioAegis Therapeutics is focused on developing therapies for inflammatory diseases through a portfolio built around plasma gelsolin (pGSN), a naturally...
plasmagelsolinimmuneproteintherapeutics
https://www.arvinas.com/
Targeted Protein Degradation Therapeutics | Arvinas
Jan 8, 2026 - Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.
targeted protein degradationtherapeuticsarvinas
https://www.photys.com/
Photys Therapeutics | Control of protein post-translational modifications
Photys Therapeutics is a proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function.
therapeuticscontrolproteinposttranslational
https://enlazatx.com/
Enlaza Therapeutics | Covalent Protein Biologics | Home
Mar 23, 2026 - Enlaza Therapeutics is pioneering the field of covalent biologics, developing a novel classes of protein therapeutics based on its proprietary War-Lock™...
therapeuticscovalentproteinbiologics
https://constructive.bio/
Protein and peptide therapeutics through genetic code expansion | Constructive Bio
We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through...
genetic code expansionconstructive bioproteinpeptidetherapeutics
https://www.kymeratx.com/reinventing-medicine/redefining-treatment-paradigms/
Reinventing Medicine with Targeted Protein Degradation | Kymera Therapeutics
Kymera is a clinical stage company pioneering targeted protein degradation to deliver revolutionary treatments for patients around the world.
targeted protein degradationreinventing medicinekymeratherapeutics
https://www.genengnews.com/topics/genome-editing/targeted-protein-degradation-drives-deal-between-enodia-therapeutics-and-kezar-life-sciences/
Targeted Protein Degradation Drives Deal Between Enodia Therapeutics and Kezar Life Sciences
Mar 12, 2026 - The acquisition of select Kezar assets is expected to enable Enodia to advance its understanding of Sec61 selectivity mechanisms.
targeted protein degradationlife sciencesdrivesdeal